Health Condition 1: A183- Tuberculosis of intestines, peritoneum and mesenteric glands
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
AIIMS Rishikesh
Eligibility
Inclusion criteria
Inclusion criteria: 1. Definite abdominal tuberculosis patients with consent given for study and follow up. 2. Probable abdominal tuberculosis patients with consent given for study and follow up.
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed as MDR (Multi drug resistant) TB. 2. Patients put on MDR TB treatment on clinical basis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Relapse: participants who had new symptoms and signs of TB after resolution of disease and completion of antituberculous treatment (ATT). 2. Clinical cure: Participants who completed treatment according to the original treatment plan without evidence of treatment failure at the end of treatment. Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Death from any cause during the treatment. 2. Treatment failure 3. Default 4. Poor adherence 5. Complete healing of active lesions, documented by endoscopy or histopathology.Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactEnono Yhoshu
All India Institute of Medical Sciences, Rishikesh, India
Outcome results
None listed